Portage Biotech Inc [NASDAQ: PRTG] gained 13.57% on the last trading session, reaching $1350000.0 price per share at the time.
Portage Biotech Inc represents 1.12 million in outstanding shares, while the company has a total market value of $6.85 million with the latest information. PRTG stock price has been found in the range of $5.41 to $6.84.
If compared to the average trading volume of 1.35M shares, PRTG reached a trading volume of 4178489 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Portage Biotech Inc [PRTG]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PRTG shares is $140.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PRTG stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Portage Biotech Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 18, 2022. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on March 07, 2022, representing the official price target for Portage Biotech Inc stock. Previously, the target price had yet another raise to $30, while Oppenheimer analysts kept a Outperform rating on PRTG stock.
The Price to Book ratio for the last quarter was 4.88, with the Price to Cash per share for the same quarter was set at 1.57.
Trading performance analysis for PRTG stock
Portage Biotech Inc [PRTG] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.45. With this latest performance, PRTG shares dropped by -22.56% in over the last four-week period, additionally plugging by 4.44% over the last 6 months – not to mention a rise of 18.18% in the past year of trading.
Portage Biotech Inc [PRTG]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -136.43%, with Return on Assets sitting at -136.43%.
An analysis of Institutional ownership at Portage Biotech Inc [PRTG]
There are presently around $4.66%, or 7.43% of PRTG stock, in the hands of institutional investors. The top three institutional holders of PRTG stocks are: ARMISTICE CAPITAL, LLC with ownership of 1.5 million shares, which is approximately 7.1866%., holding 0.3 million shares of the stock with an approximate value of $$71514.0 in PRTG stocks shares; and, currently with $$0.12 million in PRTG stock with ownership which is approximately 1.0212%.
